Abbott Said To Acquire First U.S. Production Facility In Russia

Abbott Laboratories reportedly plans to buy a Russian production facility in a deal that could rank as the nation's third largest pharmaceutical acquisition.

Abbott Laboratories reportedly plans to buy a Russian production facility in a deal that could rank as the nation's third largest pharmaceutical acquisition. A government official said Abbott had applied to acquire NPO Petrovax Pharm LLC, a non-government organization, making Abbott the first U.S. pharma to own a production plant in Russia. Petrovax was ranked 12th largest Russian drug maker in 2011 when it reported $98 million in revenues. (Click here for more

)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Manufacturing

More from Business